CareCloud, Inc. (CCLD) 10-Year Financial Performance & Capital Metrics

CCLD • • Industrial / General

HealthcareHealthcare ITClinical Software & EHR SystemsElectronic Health Record Systems

AboutCareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's Software-as-a-Service platform includes revenue cycle management, practice management, electronic health record, business intelligence, telehealth, and patient experience management solutions, as well as complementary software tools and business services for medical groups and health systems. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.Show more

Revenue $111M -5.3%
EBITDA $25M +182.6%
Net Income $8M +116.1%
EPS (Diluted) -0.28 +93.2%
Gross Margin 45.11% +14.2%
EBITDA Margin 22.79% +187.3%
Operating Margin 8.23% +120.4%
Net Margin 7.08% +117.0%
ROE 17.16% +125.3%
ROIC 13.52% +129.9%
Debt/Equity 0.07 -80.3%
Interest Coverage 10.13 +125.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 8/9
✓FCF machine: 17.1% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 11.5%
✓Trading at only 0.9x book value

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y19.73%

5Y11.46%

3Y-7.4%

TTM2.97%

Profit (Net Income) CAGR

10Y-

5Y-

3Y40.41%

TTM128.63%

EPS CAGR

10Y-

5Y-

3Y-

TTM101.24%

ROCE

10Y Avg-14.89%

5Y Avg-8.1%

3Y Avg-11%

Latest17.12%

Peer Comparison

Electronic Health Record Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
OMCLOmnicell, Inc.	2.29B	50.98	188.81	-3.04%	1.69%	1.63%	6.61%	0.31
NUTXNutex Health, Inc.	1.16B	164.21	16.91	93.8%	11.63%	26.04%	1.8%	1.69
SYSo-Young International Inc.	222.7M	2.65	-0.60	-2.09%	-51.75%	-41.37%		0.12
CCLDCareCloud, Inc.	120.83M	2.85	-10.18	-5.32%	9.8%	19.39%	15.68%	0.07
PHRPhreesia, Inc.	991.72M	16.45	-16.13	17.83%	-1.16%	-1.68%	0.84%	0.07

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	23.08M	24.49M	31.81M	50.55M	64.44M	105.12M	139.6M	138.83M	117.06M	110.84M
Revenue Growth %	0.26%	0.06%	0.3%	0.59%	0.27%	0.63%	0.33%	-0.01%	-0.16%	-0.05%
Cost of Goods Sold+	11.63M	13.42M	17.68M	31.25M	41.19M	64.82M	86.92M	84.43M	70.82M	60.84M
COGS % of Revenue	0.5%	0.55%	0.56%	0.62%	0.64%	0.62%	0.62%	0.61%	0.6%	0.55%
Gross Profit+	11.45M	11.08M	14.13M	19.29M	23.25M	40.3M	52.68M	54.39M	46.24M	49.99M
Gross Margin %	0.5%	0.45%	0.44%	0.38%	0.36%	0.38%	0.38%	0.39%	0.4%	0.45%
Gross Profit Growth %	0.49%	-0.03%	0.28%	0.37%	0.21%	0.73%	0.31%	0.03%	-0.15%	0.08%
Operating Expenses+	17.69M	19.69M	18.23M	21.76M	23.31M	48.57M	49.15M	47.78M	93.36M	40.87M
OpEx % of Revenue	0.77%	0.8%	0.57%	0.43%	0.36%	0.46%	0.35%	0.34%	0.8%	0.37%
Selling, General & Admin	12.44M	13.68M	12.84M	17.88M	19.43M	29.39M	33.06M	33.61M	31.11M	22.36M
SG&A % of Revenue	0.54%	0.56%	0.4%	0.35%	0.3%	0.28%	0.24%	0.24%	0.27%	0.2%
Research & Development	659.18K	902.19K	1.08M	1.03M	870.78K	9.31M	4.41M	4.4M	4.74M	3.78M
R&D % of Revenue	0.03%	0.04%	0.03%	0.02%	0.01%	0.09%	0.03%	0.03%	0.04%	0.03%
Other Operating Expenses	26.95K	-53.28K	83.57K	59.53K	3.01M	9.87M	11.69M	9.77M	57.51M	14.74M
Operating Income+	-4.46M	-7.9M	-4.52M	-2.54M	-421.1K	-8.27M	3.53M	6.61M	-47.12M	9.12M
Operating Margin %	-0.19%	-0.32%	-0.14%	-0.05%	-0.01%	-0.08%	0.03%	0.05%	-0.4%	0.08%
Operating Income Growth %	-0.1%	-0.77%	0.43%	0.44%	0.83%	-18.64%	1.43%	0.87%	-8.13%	1.19%
EBITDA+	140.35K	-2.79M	-222.22K	314.01K	4.47M	4.75M	19.78M	21.62M	-30.56M	25.26M
EBITDA Margin %	0.01%	-0.11%	-0.01%	0.01%	0.07%	0.05%	0.14%	0.16%	-0.26%	0.23%
EBITDA Growth %	1.11%	-20.9%	0.92%	2.41%	13.24%	0.06%	3.16%	0.09%	-2.41%	1.83%
D&A (Non-Cash Add-back)	4.6M	5.11M	4.3M	2.85M	4.89M	13.02M	16.25M	15.01M	16.55M	16.14M
EBIT	-4.26M	-7.92M	-4.17M	-1.94M	67K	-8.22M	3.45M	6.01M	-47.84M	8.91M
Net Interest Income+	-261.61K	-645.67K	-1.31M	-250.38K	-121K	-446K	-440K	-364K	-1.04M	-812K
Interest Income	26.8K	36.41K	16.94K	100.79K	262K	42K	15K	41K	154K	88K
Interest Expense	288.41K	682.08K	1.32M	351.17K	383K	488K	455K	405K	1.19M	900K
Other Income/Expense	-91.33K	-698.95K	-975.19K	243.95K	0	-439K	-536K	-1M	-1.92M	-1.11M
Pretax Income+	-4.55M	-8.6M	-5.5M	-2.3M	-679.02K	-8.71M	2.99M	5.61M	-49.04M	8.01M
Pretax Margin %	-0.2%	-0.35%	-0.17%	-0.05%	-0.01%	-0.08%	0.02%	0.04%	-0.42%	0.07%
Income Tax+	137.79K	196.8K	67.81K	-157.38K	192.78K	103K	157K	177K	-364K	160K
Effective Tax Rate %	1.03%	1.02%	1.01%	0.93%	1.28%	1.01%	0.95%	0.97%	0.99%	0.98%
Net Income+	-4.69M	-8.8M	-5.57M	-2.14M	-871.8K	-8.81M	2.84M	5.43M	-48.67M	7.85M
Net Margin %	-0.2%	-0.36%	-0.17%	-0.04%	-0.01%	-0.08%	0.02%	0.04%	-0.42%	0.07%
Net Income Growth %	-0.04%	-0.88%	0.37%	0.62%	0.59%	-9.11%	1.32%	0.92%	-9.96%	1.16%
Net Income (Continuing)	-4.69M	-8.8M	-5.57M	-2.14M	-871.8K	-8.81M	2.84M	5.43M	-48.67M	7.85M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.48	-0.88	-0.51	-0.18	-0.07	-1.79	-0.77	-0.67	-4.11	-0.28
EPS Growth %	0.25%	-0.83%	0.42%	0.65%	0.6%	-23.83%	0.57%	0.13%	-5.13%	0.93%
EPS (Basic)	-0.48	-0.88	-0.51	-0.18	-0.07	-1.79	-0.77	-0.67	-4.11	-0.28
Diluted Shares Outstanding	9.73M	10.04M	11.01M	11.72M	12.09M	12.68M	14.54M	15.11M	15.67M	16.15M
Basic Shares Outstanding	9.73M	10.04M	11.01M	11.72M	12.09M	12.68M	14.54M	15.11M	15.67M	16.15M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	10.89M	8.44M	8.93M	26.07M	31M	44.82M	35.56M	34.65M	23.24M	24.8M
Cash & Short-Term Investments	8.04M	3.48M	4.36M	14.47M	19.99M	20.93M	9.34M	12.3M	3.33M	5.14M
Cash Only	8.04M	3.48M	4.36M	14.47M	19.99M	20.93M	9.34M	12.3M	3.33M	5.14M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	2.21M	4.33M	3.88M	9.94M	9.39M	16.19M	21.73M	19.17M	17M	17.12M
Days Sales Outstanding	34.98	64.54	44.51	71.78	53.2	56.23	56.82	50.41	53	56.39
Inventory	621.49K	0	662.82K	444.44K	491K	399K	503K	381K	465K	574K
Days Inventory Outstanding	19.5	-	13.68	5.19	4.35	2.25	2.11	1.65	2.4	3.44
Other Current Assets	13.2K	13.2K	13.2K	25.2K	0	13K	1.01M	16K	2.45M	1.96M
Total Non-Current Assets+	15.79M	19.88M	16.6M	21.55M	25.4M	93.18M	105.29M	101.52M	54.58M	46.81M
Property, Plant & Equipment	1.37M	1.59M	1.39M	1.83M	6.43M	12.66M	12.34M	9.98M	9.68M	8.42M
Fixed Asset Turnover	16.82x	15.41x	22.96x	27.59x	10.02x	8.30x	11.31x	13.91x	12.09x	13.16x
Goodwill	8.97M	12.18M	12.26M	12.59M	12.63M	49.29M	61.19M	61.19M	19.19M	19.19M
Intangible Assets	5.38M	5.83M	2.51M	6.63M	5.98M	29.98M	30.78M	29.52M	25.07M	18.7M
Long-Term Investments	-483.89K	-493.27K	0	-353.74K	0	-718K	-765K	-1.03M	0	0
Other Non-Current Assets	66.98K	282.71K	436.71K	489.7K	356K	1.25M	981K	838K	641K	507K
Total Assets+	26.68M	28.32M	25.53M	47.62M	56.4M	138M	140.85M	136.17M	77.83M	71.61M
Asset Turnover	0.87x	0.86x	1.25x	1.06x	1.14x	0.76x	0.99x	1.02x	1.50x	1.55x
Asset Growth %	0.15%	0.06%	-0.1%	0.87%	0.18%	1.45%	0.02%	-0.03%	-0.43%	-0.08%
Total Current Liabilities+	5.76M	15.86M	4.32M	8.16M	11.18M	29.02M	29.56M	22.4M	23.3M	19.58M
Accounts Payable	370.44K	1.91M	991.86K	2.44M	3.49M	6.46M	5.95M	5.68M	5.8M	4.57M
Days Payables Outstanding	11.63	51.83	20.48	28.48	30.94	36.38	24.98	24.56	29.88	27.39
Short-Term Debt	3.08M	9.85M	168.72K	277.78K	284K	401K	344K	319K	292K	310K
Deferred Revenue (Current)	73.52K	41.67K	62.1K	25.36K	20K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	1.6M	2.61M	1.96M	3.69M	1.84M	12.74M	13.04M	8.49M	3.44M	1.82M
Current Ratio	1.89x	0.53x	2.07x	3.20x	2.77x	1.54x	1.20x	1.55x	1.00x	1.27x
Quick Ratio	1.78x	0.53x	1.91x	3.14x	2.73x	1.53x	1.19x	1.53x	0.98x	1.24x
Cash Conversion Cycle	42.86	-	37.72	48.49	26.62	22.09	33.95	27.5	25.51	32.45
Total Non-Current Liabilities+	6.03M	5.4M	953.23K	595.06K	2.39M	7.73M	13.36M	12.09M	12.81M	2.26M
Long-Term Debt	4.9M	4.2M	120.9K	222.4K	83K	41K	8.02M	8.01M	10.04M	26K
Capital Lease Obligations	0	0	0	0	2.04M	6.3M	4.54M	3.21M	2.52M	1.85M
Deferred Tax Liabilities	171.27K	345.53K	372.07K	164.35K	244K	1.09M	449K	525K	0	0
Other Non-Current Liabilities	916.54K	827.26K	431.64K	189.37K	0	0	0	0	0	0
Total Liabilities	11.78M	21.26M	5.28M	8.75M	13.56M	36.75M	42.92M	34.48M	36.11M	21.84M
Total Debt+	7.98M	14.05M	289.62K	500.18K	4.1M	11.47M	16.87M	13.81M	14.73M	3.47M
Net Debt	-54.62K	10.57M	-4.07M	-13.97M	-15.9M	-9.46M	7.53M	1.51M	11.4M	-1.68M
Debt / Equity	0.54x	1.99x	0.01x	0.01x	0.10x	0.11x	0.17x	0.14x	0.35x	0.07x
Debt / EBITDA	56.89x	-	-	1.59x	0.92x	2.41x	0.85x	0.64x	-	0.14x
Net Debt / EBITDA	-0.39x	-	-	-44.50x	-3.55x	-1.99x	0.38x	0.07x	-	-0.07x
Interest Coverage	-15.46x	-11.58x	-3.41x	-7.23x	-1.10x	-16.95x	7.76x	16.32x	-39.46x	10.13x
Total Equity+	14.89M	7.07M	20.25M	38.87M	42.84M	101.25M	97.93M	101.69M	41.72M	49.77M
Equity Growth %	0.04%	-0.53%	1.87%	0.92%	0.1%	1.36%	-0.03%	0.04%	-0.59%	0.19%
Book Value per Share	1.53	0.70	1.84	3.32	3.54	7.99	6.73	6.73	2.66	3.08
Total Shareholders' Equity	14.89M	7.07M	20.25M	38.87M	42.84M	101.25M	97.93M	101.69M	41.72M	49.77M
Common Stock	10.35K	10.79K	12.27K	12.57K	13K	14K	16K	16K	17K	17K
Retained Earnings	-9.15M	-17.94M	-23.51M	-24.2M	-25.08M	-33.89M	-31.05M	-25.62M	-74.48M	-66.63M
Treasury Stock	-122.03K	-662K	-662K	-662K	-662K	-662K	-662K	-662K	-662K	-662K
Accumulated OCI	-398.98K	-376.09K	-721.07K	-1.42M	-843K	-1M	-1.75M	-3.04M	-3.87M	-4M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.88M	-897.84K	281.64K	6.81M	7.62M	-892K	13.33M	21.15M	15.46M	20.64M
Operating CF Margin %	-0.08%	-0.04%	0.01%	0.13%	0.12%	-0.01%	0.1%	0.15%	0.13%	0.19%
Operating CF Growth %	0.3%	0.52%	1.31%	23.19%	0.12%	-1.12%	15.95%	0.59%	-0.27%	0.34%
Net Income	-4.69M	-8.8M	-5.57M	-2.14M	-872K	-8.81M	2.84M	5.43M	-48.67M	7.85M
Depreciation & Amortization	4.6M	5.11M	4.3M	2.91M	3.07M	13.02M	16.25M	15.6M	17.04M	16.46M
Stock-Based Compensation	628.79K	1.88M	1.49M	2.46M	3.22M	6.5M	5.4M	4.91M	4.89M	115K
Deferred Taxes	171.27K	174.26K	26.54K	-207.73K	80K	-84K	289K	76K	-525K	0
Other Non-Cash Items	-1.66M	-206.93K	1.02M	445.67K	2.94M	290K	-648K	-842K	43.84M	759K
Working Capital Changes	-936.4K	945.7K	-987.77K	3.34M	-821K	-11.81M	-10.79M	-4.03M	-1.11M	-4.55M
Change in Receivables	520.12K	-456.47K	41.74K	1.48M	1.13M	94K	-1.24M	1.82M	1.55M	-460K
Change in Inventory	0	0	0	-137.16K	-47K	92K	-104K	122K	-84K	-109K
Change in Payables	-1.69M	1.08M	-1.54M	2.15M	-1.37M	-11.88M	-10.37M	-6.59M	-3.26M	-4.65M
Cash from Investing+	-602.42K	-3.83M	-902.21K	-13.63M	-4.16M	-31.47M	-23.15M	-11.77M	-11.61M	-7.41M
Capital Expenditures	-421.86K	-463.4K	-697.21K	-1.03M	-2.02M	-2.59M	-2.93M	-2.59M	-3.06M	-1.7M
CapEx % of Revenue	0.02%	0.02%	0.02%	0.02%	0.03%	0.02%	0.02%	0.02%	0.03%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-538K	-5.16M	-7.64M	-9.18M	-8.55M	-5.71M
Cash from Financing+	9.5M	157.31K	1.84M	17.66M	1.42M	33.42M	-519K	-7.65M	-13.29M	-11.26M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-47.77K	-709.18K	-1.49M	-4.1M	-6.11M	-11.38M	-14.44M	-15.31M	-14.3M	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	-376.95K	-458.5K	-594.45K	-1.63M	927K	4.23M	-2.23M	-1.52M	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-2.3M	-1.36M	-415.57K	5.78M	5.06M	-8.64M	2.77M	9.38M	3.85M	18.95M
FCF Margin %	-0.1%	-0.06%	-0.01%	0.11%	0.08%	-0.08%	0.02%	0.07%	0.03%	0.17%
FCF Growth %	0.4%	0.41%	0.69%	14.92%	-0.13%	-2.71%	1.32%	2.39%	-0.59%	3.92%
FCF per Share	-0.24	-0.14	-0.04	0.49	0.42	-0.68	0.19	0.62	0.25	1.17
FCF Conversion (FCF/Net Income)	0.40x	0.10x	-0.05x	-3.19x	-8.74x	0.10x	4.70x	3.89x	-0.32x	2.63x
Interest Paid	256.27K	451.53K	612.28K	64.67K	67K	165K	103K	162K	927K	677K
Taxes Paid	9.76K	52.46K	9.3K	42.06K	119K	85K	282K	153K	144K	157K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-32.09%	-80.12%	-40.74%	-7.23%	-2.13%	-12.23%	2.85%	5.44%	-67.88%	17.16%
Return on Invested Capital (ROIC)	-21.97%	-36.49%	-20.06%	-9.27%	-1.22%	-10.45%	2.68%	4.75%	-45.21%	13.52%
Gross Margin	49.61%	45.22%	44.42%	38.17%	36.08%	38.34%	37.74%	39.18%	39.5%	45.11%
Net Margin	-20.31%	-35.91%	-17.49%	-4.23%	-1.35%	-8.38%	2.03%	3.91%	-41.58%	7.08%
Debt / Equity	0.54x	1.99x	0.01x	0.01x	0.10x	0.11x	0.17x	0.14x	0.35x	0.07x
Interest Coverage	-15.46x	-11.58x	-3.41x	-7.23x	-1.10x	-16.95x	7.76x	16.32x	-39.46x	10.13x
FCF Conversion	0.40x	0.10x	-0.05x	-3.19x	-8.74x	0.10x	4.70x	3.89x	-0.32x	2.63x
Revenue Growth	26.1%	6.12%	29.87%	58.9%	27.49%	63.14%	32.8%	-0.55%	-15.68%	-5.32%

Revenue by Segment

	2022	2024
Revenue Cycle Management	-	3.5M
Revenue Cycle Management Growth	-	-
Remote Patient Monitoring	-	779K
Remote Patient Monitoring Growth	-	-
Healthcare IT	125.28M	-
Healthcare IT Growth	-	-
Medical Practice Management	13.55M	-
Medical Practice Management Growth	-	-

Frequently Asked Questions

Growth & Financials

CareCloud, Inc. (CCLD) reported $114.3M in revenue for fiscal year 2024. This represents a 1033% increase from $10.1M in 2011.

CareCloud, Inc. (CCLD) saw revenue decline by 5.3% over the past year.

Yes, CareCloud, Inc. (CCLD) is profitable, generating $11.2M in net income for fiscal year 2024 (7.1% net margin).

Dividend & Returns

CareCloud, Inc. (CCLD) has a return on equity (ROE) of 17.2%. This is reasonable for most industries.

CareCloud, Inc. (CCLD) generated $21.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

CareCloud, Inc. (CCLD) 10-Year Financial Performance & Capital Metrics

CCLD • • Industrial / General

HealthcareHealthcare ITClinical Software & EHR SystemsElectronic Health Record Systems

Revenue $111M -5.3%
EBITDA $25M +182.6%
Net Income $8M +116.1%
EPS (Diluted) -0.28 +93.2%
Gross Margin 45.11% +14.2%
EBITDA Margin 22.79% +187.3%
Operating Margin 8.23% +120.4%
Net Margin 7.08% +117.0%
ROE 17.16% +125.3%
ROIC 13.52% +129.9%
Debt/Equity 0.07 -80.3%
Interest Coverage 10.13 +125.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 8/9
✓FCF machine: 17.1% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 11.5%
✓Trading at only 0.9x book value

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y19.73%

5Y11.46%

3Y-7.4%

TTM2.97%

Profit (Net Income) CAGR

10Y-

5Y-

3Y40.41%

TTM128.63%

EPS CAGR

10Y-

5Y-

3Y-

TTM101.24%

ROCE

10Y Avg-14.89%

5Y Avg-8.1%

3Y Avg-11%

Latest17.12%

Peer Comparison

Electronic Health Record Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
OMCLOmnicell, Inc.	2.29B	50.98	188.81	-3.04%	1.69%	1.63%	6.61%	0.31
NUTXNutex Health, Inc.	1.16B	164.21	16.91	93.8%	11.63%	26.04%	1.8%	1.69
SYSo-Young International Inc.	222.7M	2.65	-0.60	-2.09%	-51.75%	-41.37%		0.12
CCLDCareCloud, Inc.	120.83M	2.85	-10.18	-5.32%	9.8%	19.39%	15.68%	0.07
PHRPhreesia, Inc.	991.72M	16.45	-16.13	17.83%	-1.16%	-1.68%	0.84%	0.07

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	23.08M	24.49M	31.81M	50.55M	64.44M	105.12M	139.6M	138.83M	117.06M	110.84M
Revenue Growth %	0.26%	0.06%	0.3%	0.59%	0.27%	0.63%	0.33%	-0.01%	-0.16%	-0.05%
Cost of Goods Sold+	11.63M	13.42M	17.68M	31.25M	41.19M	64.82M	86.92M	84.43M	70.82M	60.84M
COGS % of Revenue	0.5%	0.55%	0.56%	0.62%	0.64%	0.62%	0.62%	0.61%	0.6%	0.55%
Gross Profit+	11.45M	11.08M	14.13M	19.29M	23.25M	40.3M	52.68M	54.39M	46.24M	49.99M
Gross Margin %	0.5%	0.45%	0.44%	0.38%	0.36%	0.38%	0.38%	0.39%	0.4%	0.45%
Gross Profit Growth %	0.49%	-0.03%	0.28%	0.37%	0.21%	0.73%	0.31%	0.03%	-0.15%	0.08%
Operating Expenses+	17.69M	19.69M	18.23M	21.76M	23.31M	48.57M	49.15M	47.78M	93.36M	40.87M
OpEx % of Revenue	0.77%	0.8%	0.57%	0.43%	0.36%	0.46%	0.35%	0.34%	0.8%	0.37%
Selling, General & Admin	12.44M	13.68M	12.84M	17.88M	19.43M	29.39M	33.06M	33.61M	31.11M	22.36M
SG&A % of Revenue	0.54%	0.56%	0.4%	0.35%	0.3%	0.28%	0.24%	0.24%	0.27%	0.2%
Research & Development	659.18K	902.19K	1.08M	1.03M	870.78K	9.31M	4.41M	4.4M	4.74M	3.78M
R&D % of Revenue	0.03%	0.04%	0.03%	0.02%	0.01%	0.09%	0.03%	0.03%	0.04%	0.03%
Other Operating Expenses	26.95K	-53.28K	83.57K	59.53K	3.01M	9.87M	11.69M	9.77M	57.51M	14.74M
Operating Income+	-4.46M	-7.9M	-4.52M	-2.54M	-421.1K	-8.27M	3.53M	6.61M	-47.12M	9.12M
Operating Margin %	-0.19%	-0.32%	-0.14%	-0.05%	-0.01%	-0.08%	0.03%	0.05%	-0.4%	0.08%
Operating Income Growth %	-0.1%	-0.77%	0.43%	0.44%	0.83%	-18.64%	1.43%	0.87%	-8.13%	1.19%
EBITDA+	140.35K	-2.79M	-222.22K	314.01K	4.47M	4.75M	19.78M	21.62M	-30.56M	25.26M
EBITDA Margin %	0.01%	-0.11%	-0.01%	0.01%	0.07%	0.05%	0.14%	0.16%	-0.26%	0.23%
EBITDA Growth %	1.11%	-20.9%	0.92%	2.41%	13.24%	0.06%	3.16%	0.09%	-2.41%	1.83%
D&A (Non-Cash Add-back)	4.6M	5.11M	4.3M	2.85M	4.89M	13.02M	16.25M	15.01M	16.55M	16.14M
EBIT	-4.26M	-7.92M	-4.17M	-1.94M	67K	-8.22M	3.45M	6.01M	-47.84M	8.91M
Net Interest Income+	-261.61K	-645.67K	-1.31M	-250.38K	-121K	-446K	-440K	-364K	-1.04M	-812K
Interest Income	26.8K	36.41K	16.94K	100.79K	262K	42K	15K	41K	154K	88K
Interest Expense	288.41K	682.08K	1.32M	351.17K	383K	488K	455K	405K	1.19M	900K
Other Income/Expense	-91.33K	-698.95K	-975.19K	243.95K	0	-439K	-536K	-1M	-1.92M	-1.11M
Pretax Income+	-4.55M	-8.6M	-5.5M	-2.3M	-679.02K	-8.71M	2.99M	5.61M	-49.04M	8.01M
Pretax Margin %	-0.2%	-0.35%	-0.17%	-0.05%	-0.01%	-0.08%	0.02%	0.04%	-0.42%	0.07%
Income Tax+	137.79K	196.8K	67.81K	-157.38K	192.78K	103K	157K	177K	-364K	160K
Effective Tax Rate %	1.03%	1.02%	1.01%	0.93%	1.28%	1.01%	0.95%	0.97%	0.99%	0.98%
Net Income+	-4.69M	-8.8M	-5.57M	-2.14M	-871.8K	-8.81M	2.84M	5.43M	-48.67M	7.85M
Net Margin %	-0.2%	-0.36%	-0.17%	-0.04%	-0.01%	-0.08%	0.02%	0.04%	-0.42%	0.07%
Net Income Growth %	-0.04%	-0.88%	0.37%	0.62%	0.59%	-9.11%	1.32%	0.92%	-9.96%	1.16%
Net Income (Continuing)	-4.69M	-8.8M	-5.57M	-2.14M	-871.8K	-8.81M	2.84M	5.43M	-48.67M	7.85M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.48	-0.88	-0.51	-0.18	-0.07	-1.79	-0.77	-0.67	-4.11	-0.28
EPS Growth %	0.25%	-0.83%	0.42%	0.65%	0.6%	-23.83%	0.57%	0.13%	-5.13%	0.93%
EPS (Basic)	-0.48	-0.88	-0.51	-0.18	-0.07	-1.79	-0.77	-0.67	-4.11	-0.28
Diluted Shares Outstanding	9.73M	10.04M	11.01M	11.72M	12.09M	12.68M	14.54M	15.11M	15.67M	16.15M
Basic Shares Outstanding	9.73M	10.04M	11.01M	11.72M	12.09M	12.68M	14.54M	15.11M	15.67M	16.15M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	10.89M	8.44M	8.93M	26.07M	31M	44.82M	35.56M	34.65M	23.24M	24.8M
Cash & Short-Term Investments	8.04M	3.48M	4.36M	14.47M	19.99M	20.93M	9.34M	12.3M	3.33M	5.14M
Cash Only	8.04M	3.48M	4.36M	14.47M	19.99M	20.93M	9.34M	12.3M	3.33M	5.14M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	2.21M	4.33M	3.88M	9.94M	9.39M	16.19M	21.73M	19.17M	17M	17.12M
Days Sales Outstanding	34.98	64.54	44.51	71.78	53.2	56.23	56.82	50.41	53	56.39
Inventory	621.49K	0	662.82K	444.44K	491K	399K	503K	381K	465K	574K
Days Inventory Outstanding	19.5	-	13.68	5.19	4.35	2.25	2.11	1.65	2.4	3.44
Other Current Assets	13.2K	13.2K	13.2K	25.2K	0	13K	1.01M	16K	2.45M	1.96M
Total Non-Current Assets+	15.79M	19.88M	16.6M	21.55M	25.4M	93.18M	105.29M	101.52M	54.58M	46.81M
Property, Plant & Equipment	1.37M	1.59M	1.39M	1.83M	6.43M	12.66M	12.34M	9.98M	9.68M	8.42M
Fixed Asset Turnover	16.82x	15.41x	22.96x	27.59x	10.02x	8.30x	11.31x	13.91x	12.09x	13.16x
Goodwill	8.97M	12.18M	12.26M	12.59M	12.63M	49.29M	61.19M	61.19M	19.19M	19.19M
Intangible Assets	5.38M	5.83M	2.51M	6.63M	5.98M	29.98M	30.78M	29.52M	25.07M	18.7M
Long-Term Investments	-483.89K	-493.27K	0	-353.74K	0	-718K	-765K	-1.03M	0	0
Other Non-Current Assets	66.98K	282.71K	436.71K	489.7K	356K	1.25M	981K	838K	641K	507K
Total Assets+	26.68M	28.32M	25.53M	47.62M	56.4M	138M	140.85M	136.17M	77.83M	71.61M
Asset Turnover	0.87x	0.86x	1.25x	1.06x	1.14x	0.76x	0.99x	1.02x	1.50x	1.55x
Asset Growth %	0.15%	0.06%	-0.1%	0.87%	0.18%	1.45%	0.02%	-0.03%	-0.43%	-0.08%
Total Current Liabilities+	5.76M	15.86M	4.32M	8.16M	11.18M	29.02M	29.56M	22.4M	23.3M	19.58M
Accounts Payable	370.44K	1.91M	991.86K	2.44M	3.49M	6.46M	5.95M	5.68M	5.8M	4.57M
Days Payables Outstanding	11.63	51.83	20.48	28.48	30.94	36.38	24.98	24.56	29.88	27.39
Short-Term Debt	3.08M	9.85M	168.72K	277.78K	284K	401K	344K	319K	292K	310K
Deferred Revenue (Current)	73.52K	41.67K	62.1K	25.36K	20K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	1.6M	2.61M	1.96M	3.69M	1.84M	12.74M	13.04M	8.49M	3.44M	1.82M
Current Ratio	1.89x	0.53x	2.07x	3.20x	2.77x	1.54x	1.20x	1.55x	1.00x	1.27x
Quick Ratio	1.78x	0.53x	1.91x	3.14x	2.73x	1.53x	1.19x	1.53x	0.98x	1.24x
Cash Conversion Cycle	42.86	-	37.72	48.49	26.62	22.09	33.95	27.5	25.51	32.45
Total Non-Current Liabilities+	6.03M	5.4M	953.23K	595.06K	2.39M	7.73M	13.36M	12.09M	12.81M	2.26M
Long-Term Debt	4.9M	4.2M	120.9K	222.4K	83K	41K	8.02M	8.01M	10.04M	26K
Capital Lease Obligations	0	0	0	0	2.04M	6.3M	4.54M	3.21M	2.52M	1.85M
Deferred Tax Liabilities	171.27K	345.53K	372.07K	164.35K	244K	1.09M	449K	525K	0	0
Other Non-Current Liabilities	916.54K	827.26K	431.64K	189.37K	0	0	0	0	0	0
Total Liabilities	11.78M	21.26M	5.28M	8.75M	13.56M	36.75M	42.92M	34.48M	36.11M	21.84M
Total Debt+	7.98M	14.05M	289.62K	500.18K	4.1M	11.47M	16.87M	13.81M	14.73M	3.47M
Net Debt	-54.62K	10.57M	-4.07M	-13.97M	-15.9M	-9.46M	7.53M	1.51M	11.4M	-1.68M
Debt / Equity	0.54x	1.99x	0.01x	0.01x	0.10x	0.11x	0.17x	0.14x	0.35x	0.07x
Debt / EBITDA	56.89x	-	-	1.59x	0.92x	2.41x	0.85x	0.64x	-	0.14x
Net Debt / EBITDA	-0.39x	-	-	-44.50x	-3.55x	-1.99x	0.38x	0.07x	-	-0.07x
Interest Coverage	-15.46x	-11.58x	-3.41x	-7.23x	-1.10x	-16.95x	7.76x	16.32x	-39.46x	10.13x
Total Equity+	14.89M	7.07M	20.25M	38.87M	42.84M	101.25M	97.93M	101.69M	41.72M	49.77M
Equity Growth %	0.04%	-0.53%	1.87%	0.92%	0.1%	1.36%	-0.03%	0.04%	-0.59%	0.19%
Book Value per Share	1.53	0.70	1.84	3.32	3.54	7.99	6.73	6.73	2.66	3.08
Total Shareholders' Equity	14.89M	7.07M	20.25M	38.87M	42.84M	101.25M	97.93M	101.69M	41.72M	49.77M
Common Stock	10.35K	10.79K	12.27K	12.57K	13K	14K	16K	16K	17K	17K
Retained Earnings	-9.15M	-17.94M	-23.51M	-24.2M	-25.08M	-33.89M	-31.05M	-25.62M	-74.48M	-66.63M
Treasury Stock	-122.03K	-662K	-662K	-662K	-662K	-662K	-662K	-662K	-662K	-662K
Accumulated OCI	-398.98K	-376.09K	-721.07K	-1.42M	-843K	-1M	-1.75M	-3.04M	-3.87M	-4M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.88M	-897.84K	281.64K	6.81M	7.62M	-892K	13.33M	21.15M	15.46M	20.64M
Operating CF Margin %	-0.08%	-0.04%	0.01%	0.13%	0.12%	-0.01%	0.1%	0.15%	0.13%	0.19%
Operating CF Growth %	0.3%	0.52%	1.31%	23.19%	0.12%	-1.12%	15.95%	0.59%	-0.27%	0.34%
Net Income	-4.69M	-8.8M	-5.57M	-2.14M	-872K	-8.81M	2.84M	5.43M	-48.67M	7.85M
Depreciation & Amortization	4.6M	5.11M	4.3M	2.91M	3.07M	13.02M	16.25M	15.6M	17.04M	16.46M
Stock-Based Compensation	628.79K	1.88M	1.49M	2.46M	3.22M	6.5M	5.4M	4.91M	4.89M	115K
Deferred Taxes	171.27K	174.26K	26.54K	-207.73K	80K	-84K	289K	76K	-525K	0
Other Non-Cash Items	-1.66M	-206.93K	1.02M	445.67K	2.94M	290K	-648K	-842K	43.84M	759K
Working Capital Changes	-936.4K	945.7K	-987.77K	3.34M	-821K	-11.81M	-10.79M	-4.03M	-1.11M	-4.55M
Change in Receivables	520.12K	-456.47K	41.74K	1.48M	1.13M	94K	-1.24M	1.82M	1.55M	-460K
Change in Inventory	0	0	0	-137.16K	-47K	92K	-104K	122K	-84K	-109K
Change in Payables	-1.69M	1.08M	-1.54M	2.15M	-1.37M	-11.88M	-10.37M	-6.59M	-3.26M	-4.65M
Cash from Investing+	-602.42K	-3.83M	-902.21K	-13.63M	-4.16M	-31.47M	-23.15M	-11.77M	-11.61M	-7.41M
Capital Expenditures	-421.86K	-463.4K	-697.21K	-1.03M	-2.02M	-2.59M	-2.93M	-2.59M	-3.06M	-1.7M
CapEx % of Revenue	0.02%	0.02%	0.02%	0.02%	0.03%	0.02%	0.02%	0.02%	0.03%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-538K	-5.16M	-7.64M	-9.18M	-8.55M	-5.71M
Cash from Financing+	9.5M	157.31K	1.84M	17.66M	1.42M	33.42M	-519K	-7.65M	-13.29M	-11.26M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-47.77K	-709.18K	-1.49M	-4.1M	-6.11M	-11.38M	-14.44M	-15.31M	-14.3M	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	-376.95K	-458.5K	-594.45K	-1.63M	927K	4.23M	-2.23M	-1.52M	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-2.3M	-1.36M	-415.57K	5.78M	5.06M	-8.64M	2.77M	9.38M	3.85M	18.95M
FCF Margin %	-0.1%	-0.06%	-0.01%	0.11%	0.08%	-0.08%	0.02%	0.07%	0.03%	0.17%
FCF Growth %	0.4%	0.41%	0.69%	14.92%	-0.13%	-2.71%	1.32%	2.39%	-0.59%	3.92%
FCF per Share	-0.24	-0.14	-0.04	0.49	0.42	-0.68	0.19	0.62	0.25	1.17
FCF Conversion (FCF/Net Income)	0.40x	0.10x	-0.05x	-3.19x	-8.74x	0.10x	4.70x	3.89x	-0.32x	2.63x
Interest Paid	256.27K	451.53K	612.28K	64.67K	67K	165K	103K	162K	927K	677K
Taxes Paid	9.76K	52.46K	9.3K	42.06K	119K	85K	282K	153K	144K	157K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-32.09%	-80.12%	-40.74%	-7.23%	-2.13%	-12.23%	2.85%	5.44%	-67.88%	17.16%
Return on Invested Capital (ROIC)	-21.97%	-36.49%	-20.06%	-9.27%	-1.22%	-10.45%	2.68%	4.75%	-45.21%	13.52%
Gross Margin	49.61%	45.22%	44.42%	38.17%	36.08%	38.34%	37.74%	39.18%	39.5%	45.11%
Net Margin	-20.31%	-35.91%	-17.49%	-4.23%	-1.35%	-8.38%	2.03%	3.91%	-41.58%	7.08%
Debt / Equity	0.54x	1.99x	0.01x	0.01x	0.10x	0.11x	0.17x	0.14x	0.35x	0.07x
Interest Coverage	-15.46x	-11.58x	-3.41x	-7.23x	-1.10x	-16.95x	7.76x	16.32x	-39.46x	10.13x
FCF Conversion	0.40x	0.10x	-0.05x	-3.19x	-8.74x	0.10x	4.70x	3.89x	-0.32x	2.63x
Revenue Growth	26.1%	6.12%	29.87%	58.9%	27.49%	63.14%	32.8%	-0.55%	-15.68%	-5.32%

Revenue by Segment

	2022	2024
Revenue Cycle Management	-	3.5M
Revenue Cycle Management Growth	-	-
Remote Patient Monitoring	-	779K
Remote Patient Monitoring Growth	-	-
Healthcare IT	125.28M	-
Healthcare IT Growth	-	-
Medical Practice Management	13.55M	-
Medical Practice Management Growth	-	-

Frequently Asked Questions

Growth & Financials

CareCloud, Inc. (CCLD) reported $114.3M in revenue for fiscal year 2024. This represents a 1033% increase from $10.1M in 2011.

CareCloud, Inc. (CCLD) saw revenue decline by 5.3% over the past year.

Yes, CareCloud, Inc. (CCLD) is profitable, generating $11.2M in net income for fiscal year 2024 (7.1% net margin).

Dividend & Returns

CareCloud, Inc. (CCLD) has a return on equity (ROE) of 17.2%. This is reasonable for most industries.

CareCloud, Inc. (CCLD) generated $21.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.